Active intermittent Theta Burst Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)
This trial will test if a non-invasive brain stimulation can help improve symptoms for adolescents with ADHD by changing how the brain works.
4 Primary · 0 Secondary · Reporting Duration: Theta-gamma coupling will be obtained before the 1st session, and 24 hours after the 1st, 5th, and 10th sessions. Statistical modeling will examine the CHANGE across these four time points. This change is considered a single primary outcome variable.
2 Treatment Groups
Active intermittent Theta Burst Stimulation
1 of 2
Sham intermittent Theta Burst Stimulation
1 of 2
25 Total Participants · 2 Treatment Groups
Primary Treatment: Active intermittent Theta Burst Stimulation · Has Placebo Group · N/A
Who is running the clinical trial?
Age 13 - 18 · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
|E. P. Bradley Hospital||100.0%|
What portion of applicants met pre-screening criteria?
Frequently Asked Questions
Is the eligibility age for this research study limited to those under 35 years old?
"To be eligible for consideration, applicants must lie between 13 and 18 years of age. Data indicates that 98 trials are available to those younger than 18 while 28 clinical studies cater to the needs of individuals above 65." - Anonymous Online Contributor
Is this research study open for recruitment at the present moment?
"Consistent with the data available on clinicaltrials.gov, this medical investigation is presently enrolling subjects. The study was first published on October 1st 2021 and its details were last modified on March 17th 2022." - Anonymous Online Contributor
What criteria must potential participants meet to be eligible for this research?
"This clinical trial seeks 25 minors (ages 13-18) with a confirmed diagnosis of Attention Deficit Hyperactivity Disorder. In order to qualify, participants must be fluent in English and their parents or guardians must provide consent via assent. Furthermore, the BRIEF-2 Working Memory score should exceed 1 SD above normative mean and participants IQ needs to surpass 80. While medication for ADHD is allowed during study participation, no modifications can take place without physician approval; otherwise it may result in patient's withdrawal from the trial." - Anonymous Online Contributor
How many volunteers have enrolled in this clinical experiment?
"Affirmative, the clinicaltrials.gov website reveals that this medical trial has been actively recruiting since October 1st 2021 and was revised on March 17th 2022. This study seeks 25 participants from a single venue." - Anonymous Online Contributor